当前位置:药药网 / 药品研发 / 美国药品上市后承诺数据库
BioThrax, Anthrax Vaccine Adsorbed
申请企业
Emergent BioDefense Operations Lansing LLC
药品名称
BioThrax, Anthrax Vaccine Adsorbed
承诺描述
Final Protocol Submission: November 30, 2016 Study/Trial Completion: To be determined should an event occur. Final Report Submission: To be determined should an event occur.